Yan Huang

ORCID: 0000-0003-2789-5580 · 22 papers in corpus · active 2011-2026

Study types

  • article 15
  • other 2
  • review 2
  • case-report 1
  • preprint 1

Condition tags

  • endometriosis 19
  • dysmenorrhea 4
  • dyspareunia 3
  • infertility 2
  • die_deep_infiltrating 2
  • adenomyosis 2
  • chronic_pelvic_pain 1
2026
·doi:10.64898/2026.05.11.724261
review 2026
Journal of thrombosis and thrombolysis ·doi:10.1007/s11239-025-03157-4
article 2025
American journal of reproductive immunology (New York, N.Y. : 1989) ·doi:10.1111/aji.70064

PROBLEM: The relationship between abortion and endometriosis (EMS) has been inconsistent in previous observational studies and remains controversial. We intended to examine the causal relationship between abortion and EMS. METHODS OF STUDY:…

article 2025
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-025-03596-1
article 2025
Biology of reproduction ·doi:10.1093/biolre/ioaf153

Endometriosis has been increasingly associated with the aberrant regulation of non-coding RNAs (ncRNAs), particularly long non-coding RNAs (lncRNAs) and microRNAs (miRNAs). Despite the growing recognition of their biological significance, t…

article 2024
Open medicine (Warsaw, Poland) ·doi:10.1515/med-2023-0794

Abstract This study aimed to investigate the changes of serum carbohydrate antigen 125 (CA125) and prostaglandin E2 (PGE2) in patients with adenomyosis before and after treatment with high-intensity focused ultrasound (HIFU) combined with g…

article 2024
Annals of medicine ·doi:10.1080/07853890.2024.2402942

OBJECTIVE: This prospective observational study aims to demonstrate the clinical efficacy of dienogest in treating endometriomas with a maximum diameter of ≥4 cm. METHODS: = 81) with endometriomas (diameter of ≥4 cm) were enrolled and admin…

article 2024
World journal of clinical cases ·doi:10.12998/wjcc.v12.i21.4601

BACKGROUND: Currently, the use of dienogest in clinical practice has increased significantly, and many studies have focused on its effectiveness and safety in the treatment of endometriosis and adenomyosis; however, the effects of treatment…

article 2024
Journal of genetics and genomics = Yi chuan xue bao ·doi:10.1016/j.jgg.2023.12.012
article 2024
·doi:10.31083/j.ceog5102051

Background: Endometriosis (EM), a gynecological disorder that is dependent on estrogen and causes inflammation, is prevalent among women of reproductive age and is considered a chronic condition. The involvement of noncoding RNAs in exosome…

other 2023
Anti-cancer drugs ·doi:10.1097/CAD.0000000000001405

MiR-181a suppresses the proliferation of mouse granulosa cells, which participate in polycystic ovary syndrome (PCOS), suggesting the potential role of miR-181a in PCOS. Our bioinformatics analysis revealed that miR-181a could bind CDKN2B-A…

case-report 2023
The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception ·doi:10.1080/13625187.2023.2216329

PURPOSE: Laparotomic or hysteroscopic myomectomy, and high-intensity focussed ultrasound (HIFU), can be used in the treatment of Type 2 myomas with a > 50% intramural component. Hysteroscopic electroresection may damage the remaining endome…

article 2023
World journal of clinical cases ·doi:10.12998/wjcc.v11.i27.6631

BACKGROUND: Polypoid endometriosis (PEM) is a rare and unique type of endometriosis. To date, no article has provided a systematic report of this disease. The current article provides a complete report on rare PEM based on ultrasound, magne…

review 2022
Biomolecules ·doi:10.3390/biom12111624

Common uterine diseases include endometriosis, uterine fibroids, endometrial polyps, endometrial hyperplasia, endometrial cancer, and endometrial dysfunction causing infertility. Patients with uterine diseases often suffer from abdominal pa…

other 2022
Medicine ·doi:10.1097/MD.0000000000028766

Triptorelin is one of the most commonly used gonadotropin-releasing hormone agonists and has been used in the treatment of deep infiltrating endometriosis (DIE). This study aimed to evaluate the efficacy and safety of up to 24 weeks of trip…

article 2021
Archives of gynecology and obstetrics ·doi:10.1007/s00404-020-05900-z

PURPOSE: Endometriosis is a common, chronic gynecological disease that affects women's fertility potential. Dydrogesterone is an effective and safe drug that is under-utilized due to limited clinical research. The purpose of this evidence m…

preprint 2020
·doi:10.22541/au.158981325.53850315

OBJECTIVE: To evaluate the efficacy and safety of up to 24 weeks of triptorelin treatment after conservative surgery for deep infiltrating endometriosis (DIE). DESIGN: Multicentre, prospective, non-interventional. SETTING: 18 tertiary hospi…

article 2014
Mutation research ·doi:10.1016/j.mrfmmm.2014.01.003
article 2014
·doi:10.1016/j.fertnstert.2014.07.025
article 2012
·doi:10.3760/cma.j.issn.1008-6706.2012.04.008

Objective To study the clinical effect of GnRH-α in treatment of patients with endometriosis after laparoscope surgery.Methods 185 endometriosis patients who got laparoscope surgery were randomly divided into the observation group(93 cases)…

article 2011
·doi:10.3877/cma.j.issn.1673-5250.2011.04.007

Objective To study the expression of leptin and leptin receptor (Ob-R)in ectopic and eutopic endometrium from women with ovarian endometriosis(EMs), and to explore their role in pathogenesis of ovarian endometriosis. Methods Twenty-f…

article 2011
Fertility and sterility ·doi:10.1016/j.fertnstert.2011.04.067